Skip to main content
RIGL logo

RIGL · Rigel Pharmaceuticals Inc · Proposed Sales

Track RIGL — free
$42.53 -0.39 (-0.91%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$800.84M
Shares
18.83M
Volume · Nov 18 304.84K Avg daily vol (3M) 252.93K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-06-22 Ali-Jackson Kamil 2,500
2026-05-26 Ali-Jackson Kamil 2,500
2026-02-20 MOOS WALTER H 4,000
2025-02-05 Furey Raymond J. 1,339
2025-02-05 Schorno Dean L 1,734
2025-02-05 RODRIGUEZ RAUL R 4,400
2025-02-05 Santos David A 1,796
2025-02-04 Santos David A 2,125
2025-02-04 Schorno Dean L 2,036
2025-02-04 RODRIGUEZ RAUL R 4,952
2025-02-04 Furey Raymond J. 1,448
2025-01-24 Masuda Esteban 4,999
Showing 1–12 of 12 filings
Key facts CIK 1034842 CUSIP 766559702 13F (30d) 182 filings 156 filers Visit website Investor relations